<SEC-DOCUMENT>0000849146-20-000179.txt : 20201117
<SEC-HEADER>0000849146-20-000179.hdr.sgml : 20201117
<ACCEPTANCE-DATETIME>20201117160527
ACCESSION NUMBER:		0000849146-20-000179
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20201112
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20201117
DATE AS OF CHANGE:		20201117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		201321205

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lfvn-20201112.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556,d:c138fd41ff1a4218bf044b74985abfe6--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lfvn-20201112</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl80L2ZyYWc6YzQyZTQ2ODY1YjJlNDM5ZWI3NWQyYzk3OTg5YTQ2OWIvdGFibGU6OTU2MzJiMTU3YjkzNDk2MTg1N2JiZDg2YTZjNjUzZmUvdGFibGVyYW5nZTo5NTYzMmIxNTdiOTM0OTYxODU3YmJkODZhNmM2NTNmZV8yLTEtMS0xLTA_facbbb30-3546-46d0-83bf-ef24114ccb74">0000849146</ix:nonNumeric><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl80L2ZyYWc6YzQyZTQ2ODY1YjJlNDM5ZWI3NWQyYzk3OTg5YTQ2OWIvdGFibGU6OTU2MzJiMTU3YjkzNDk2MTg1N2JiZDg2YTZjNjUzZmUvdGFibGVyYW5nZTo5NTYzMmIxNTdiOTM0OTYxODU3YmJkODZhNmM2NTNmZV81LTEtMS0xLTA_e805cb22-2e62-4193-9cf6-6c90a2a8168d">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lfvn-20201112.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-12</xbrli:startDate><xbrli:endDate>2020-11-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic138fd41ff1a4218bf044b74985abfe6_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">&#160;______________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg1_fdf22042-29fc-4c0f-980e-9897171cbaf1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8xMDk5NTExOTMxNjk1_e97c8693-7e95-4f56-a342-42a94f940c66">November 12, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg2_d840355f-b461-4b6f-9b84-c5312274f8db">LIFEVANTAGE CORP</ix:nonNumeric>ORATION</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:36.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTAtMS0xLTA_c80c169b-c799-44b3-9d38-938ef4f4aa74">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTItMS0xLTA_e74e9174-c3d5-488d-881f-5c06006ce05e">001-35647</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTUtMS0xLTA_81fb862d-b68b-4729-b96b-bb7771fd7988">90-0224471</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg3_da89e1a0-6ea8-453d-ac0d-2e679921b3e3">9785 S. Monroe Street</ix:nonNumeric>, <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkx_de7e0fd7-7b38-4631-9e66-d6f0fc0ae322">Suite 400</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzky_1180789f-b75a-4844-9210-a99e7ce9005b">Sandy</ix:nonNumeric>, <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg0_bca28d30-86a3-4cd8-b51e-594de38c7a29">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkz_ebd75ea0-f897-443d-9049-9abb16a361ca">84070</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg4_cb7b2c17-9cc9-4eae-a704-cb02a7ac3404">801</ix:nonNumeric>) <ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg5_0cb71eb2-c694-4743-b3c9-64f6ba1af50c">432-9000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant's telephone number)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18wLTAtMS0xLTA_0a7e8bd4-cb76-4607-bbbd-1fdda6432bd9">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18xLTAtMS0xLTA_f192088e-8573-457c-b223-2ab50a2d49d8">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18yLTAtMS0xLTA_4a5da456-28ef-4abd-9e49-f1ce72c6f22f">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18zLTAtMS0xLTA_9c856e30-a26b-4264-9cc3-5cdeea801b63">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:31.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTAtMS0xLTA_81d991a6-2234-45e1-8b0a-01dc2c013ab2">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTItMS0xLTA_c7b25340-5aee-4252-a78f-311b758682bf">LFVN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTQtMS0xLTA_76273a2e-8957-43c8-ad98-e603fef8890f">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkw_fa736eb2-fc28-4375-b59f-a36e3dd652f4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:14.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt"><span><br/></span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the fiscal 2021 annual meeting of stockholders held on November 12, 2020 (the &#8220;Annual Meeting&#8221;) of LifeVantage Corporation (the &#8220;Company&#8221;), the Company&#8217;s stockholders approved an amendment to the 2017 Long-Term Incentive Plan (the &#8220;Plan&#8221;) to increase the number of shares of the Company&#8217;s common stock available for issuance under the Plan by 650,000 shares, as described in the Company&#8217;s proxy statement for the Annual Meeting and other soliciting materials filed with the Securities and Exchange Commission, (the &#8220;Amended Plan&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A copy of the Amended Plan is filed as Exhibit 10.1 to this report and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:14.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.07</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt"><span><br/></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the Annual Meeting on November 12, 2020.  Of the 14,241,776 shares of the Company&#8217;s common stock outstanding as of the record date, 12,104,683 shares, or 84.99% were represented at the Annual Meeting either in person or by proxy. The following proposals were submitted to a vote of the Company&#8217;s stockholders at the Annual Meeting:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;To elect the following six director nominees to the Company&#8217;s board of directors to hold office until the Company&#8217;s fiscal 2022 annual meeting of stockholders or until their respective successors are elected and qualified: Mr. Michael A. Beindorff, Ms. Erin Brockovich, Mr. Raymond B. Greer, Mr. Vinayak R. Hegde, Mr. Darwin K. Lewis, and Mr. Garry Mauro.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;To approve an amendment to the 2017 Long-Term Incentive Plan;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.    To approve, on an advisory basis, a resolution approving the compensation of the Company&#8217;s named executive officers; and</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.    To ratify the selection of WSRP, LLC as the Company&#8217;s independent registered public accounting firm for the Company&#8217;s fiscal year ending June&#160;30, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposals submitted to a vote of the Company&#8217;s stockholders at the Annual Meeting are more fully described in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final voting results of each proposal were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proposal 1 &#8211; Election of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s stockholders elected each of the six director nominees listed above to the Company&#8217;s board of directors to serve until the Company&#8217;s fiscal 2022 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.346%"><tr><td style="width:1.0%"></td><td style="width:28.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.905%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr.&#160;Michael&#160;A. Beindorff</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,219,038</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703,788</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,778</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ms. Erin Brockovich</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,385,811</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544,349</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Raymond B. Greer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214,863</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,698</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,043</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Vinayak R. Hegde</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,568,122</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,924</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,558</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Darwin K. Lewis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,418,623</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,067</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,914</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Garry Mauro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,266,611</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,409</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proposal 2 &#8211; Amendment to the 2017 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s stockholders approved the amendment to the 2017 Long-Term Incentive Plan. Votes cast were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,641,319</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275,752</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,533</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proposal 3 &#8211; Approval of Compensation of the Company&#8217;s Named Executive Officers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s stockholders approved, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers. Votes cast were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,428,181</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476,704</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,719</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171,079</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proposal 4 &#8211; Ratification of Selection of Independent Registered Public Accounting Firm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s stockholders ratified the selection of WSRP, LLC as the Company&#8217;s independent registered public accounting firm for the fiscal year ending June&#160;30, 2021. Votes cast were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:32.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstain</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,966,679</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,468</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,536</span></td></tr></table></div><div style="margin-bottom:7pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:14.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-right:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d) Exhibits<br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.307%"><tr><td style="width:1.0%"></td><td style="width:18.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.630%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a2017ltip.htm">LifeVantage Corporation 2017 Long-Term Incentive Plan, as amended.</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">SIGNATURE</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 17, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:justify"><span><br/></span></div><div style="padding-left:2pt;padding-right:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Steven R. Fife</span></div><div style="padding-left:2pt;padding-right:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name: Steven R. Fife</span></div><div style="padding-left:2pt;padding-right:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title: Interim President and Chief Executive Officer, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a2017ltip.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i0459e0f17a484cb6b222eddb0193ddaf_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">2017 LONG-TERM INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Adopted on December 6, 2016,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">Effective on February 16, 2017 and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">Amended on November 16, 2017, January 19, 2018, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">September 20, 2018, and August 27, 2020)</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1.  INTRODUCTION</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board adopted the LifeVantage Corporation 2017 Long-Term Incentive Plan on the Adoption Date conditioned upon and subject to obtaining Company stockholder approval.  Stockholder approval for the Plan was obtained on February 16, 2017.  The Board amended the Plan on November 16, 2017 and January 19, 2018, pursuant to which 425,000 Shares in the aggregate were added to the reserve under the Plan, such that the maximum aggregate number of Shares that may be issued under the Plan (and pursuant to the exercise of Incentive Stock Options) shall be 1,550,000 Shares (the &#8220;2017&#47;2018 Amendment&#8221;).  The 2017&#47;2018 Amendment was approved by the Company&#8217;s stockholders on February 2, 2018.  On September 20, 2018, the Board further amended the Plan to add 715,000 Shares to the reserve under the Plan and increase the maximum aggregate number of Shares that may be issued under the Plan (and pursuant to the exercise of Incentive Stock Options) from 1,550,000 Shares to 2,265,000 (the &#8220;September 2018 Amendment&#8221;).  The September 2018 Amendment was approved by the Company&#8217;s stockholders on November 15, 2018. On August 27, 2020, the Board further amended the Plan to add 650,000 Shares to the reserve under the Plan to increase the maximum aggregate number of Shares that may be issued under the Plan (and pursuant to the exercise of Incentive Stock Options) from 2,265,000 to 2,915,000 (the &#34;August 2020 Amendment&#34;). The August 2020 Amendment was approved by the Company&#8217;s stockholders on November 12, 2020.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purposes of the Plan are to (i) attract and retain the services of persons eligible to participate in the Plan&#59; (ii) motivate Selected Employees, by means of appropriate equity and performance based incentives, to achieve long-term performance goals&#59; (iii) provide equity and performance based incentive compensation opportunities that are competitive with those of other similar companies&#59; and (iv) further align Participants' interests with those of the Company's other stockholders and thereby promote the financial interests of the Company and its affiliates and enhancement of stockholder return.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan seeks to achieve this purpose by providing for Awards in the form of Options (which may constitute Incentive Stock Options or Nonstatutory Stock Options), Stock Appreciation Rights, Restricted Stock Grants, Stock Units and&#47;or Cash Awards, as well as any other form of equity award consistent with the terms of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms shall have the meaning provided in Section 2 unless otherwise provided in this Plan or any related Award Agreement.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 2.  DEFINITIONS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adoption Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means December 6, 2016.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any entity other than a Subsidiary, if the Company and&#47;or one or more Subsidiaries own not less than 50% of such entity. For purposes of determining an individual&#8217;s &#8220;Service,&#8221; this definition shall include any entity other than a Subsidiary, if the Company, a Parent and&#47;or one or more Subsidiaries own not less than 50% of such entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any award, under this Plan, to a Selected Employee of an Option, SAR, Restricted Stock Grant, Stock Unit or to a Covered Employee of any Cash Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Stock Option Agreement, a SAR Agreement, a Restricted Stock Grant Agreement, a Stock Unit Agreement or such other agreement evidencing an Award granted under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company, as constituted from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award of a bonus opportunity, under this Plan, to a Covered Employee that (i) is payable in cash, (ii) is not an Option, SAR, Restricted Stock Grant or Stock Unit, (iii) is paid based on achievement of Performance Goal(s) and (iv) may be intended to qualify as performance-based compensation under Code Section 162(m).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, to the extent that a Stock Option Agreement so provides and as permitted by applicable law and in accordance with any procedures established by the Committee, an arrangement whereby payment of some or all of the aggregate Exercise Price may be made all or in part by delivery of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company. Cashless Exercise may also be utilized to satisfy an Option's tax withholding obligations as provided in Section 14(b).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, except as may otherwise be provided in a Participant&#8217;s employment agreement or applicable Award Agreement (and in such case the employment agreement or Award Agreement shall govern as to the definition of Cause), (i) dishonesty or fraud, (ii) serious willful misconduct, (iii) unauthorized use or disclosure of confidential information or trade secrets, (iv) conviction or confession of a felony, or (v) any other act or omission by a Participant that, in the opinion of the Company, could reasonably be expected to adversely affect the Company&#8217;s or a Subsidiary&#8217;s or an Affiliate&#8217;s business, financial condition, prospects and&#47;or reputation. In each of the foregoing subclauses (i) through (v), whether or not a &#8220;Cause&#8221; event has occurred will be determined by the Company&#8217;s chief human resources officer or other person performing that function or, in the case of Participants who are Directors or Officers or Section 16 Persons, the Board, each of whose determination shall be final, conclusive and binding. A Participant&#8217;s Service shall be deemed to have terminated for Cause if, after the Participant&#8217;s Service has terminated, facts and circumstances are discovered that would have justified a termination for Cause, including, without limitation, violation of material Company policies or breach of confidentiality or other restrictive covenants that may apply to the Participant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, except as may otherwise be provided in a Participant&#8217;s employment agreement or applicable Award Agreement (and in such case the employment agreement or Award Agreement shall govern as to the definition of Change in Control), the occurrence of any one or more of the following&#58; (i) any merger, consolidation or business combination in which the stockholders of the Company immediately prior to the merger, consolidation or business combination do not own at least a majority of the outstanding equity interests of the surviving parent entity, (ii) the sale of all or substantially all of the Company's assets, (iii) the acquisition of beneficial ownership or control of (including, without limitation, power to vote) a majority of the outstanding Shares by any person or entity (including a &#8220;group&#8221; as defined by or under Section 13(d)(3) of the Exchange Act), (iv) the dissolution or liquidation of the Company, or (v) a contested election of directors, as a result of which or in connection with which the persons who were directors of the Company before such election or their nominees cease to constitute a majority of the Board.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company's incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company's securities immediately before such transactions. In addition, if a Change in Control constitutes a payment event with respect to any Award which provides for a deferral of compensation and is subject to Code Section 409A, then notwithstanding anything to the contrary in the Plan or applicable Award Agreement the transaction with respect to such Award must also constitute a &#8220;change in control event&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5) to the extent required by Code Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended, and the regulations and interpretations promulgated thereunder.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a committee described in Section 3.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s common stock, $0.001 par value per Share, and any other securities into which such shares are changed, for which such shares are exchanged or which may be issued in respect thereof.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means LifeVantage Corporation, a Colorado corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a consultant or adviser who provides bona fide services to the Company, a Parent, a Subsidiary or an Affiliate, other than as an Employee, Director or Non-Employee Director and who qualifies as a consultant or adviser under Instruction A.1.(a)(1) of Form S-8 under the Securities Act.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covered Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those individuals whose compensation is subject to the deduction limitations of Code Section 162(m).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board who is also an Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, except as may otherwise be provided in a Participant&#8217;s employment agreement or applicable Award Agreement (and in such case the employment agreement or Award Agreement shall govern as to the definition of Disability), that the Participant is classified as disabled under a long-term disability policy of the Company or, if no such policy applies, the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any individual who is a common-law employee of the Company, or of a Parent, or of a Subsidiary or of an Affiliate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Award other than a Cash Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, in the case of an Option, the amount for which a Share may be purchased upon exercise of such Option, as specified in the applicable Stock Option Agreement. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; in the case of a SAR, means an amount, as specified in the applicable SAR Agreement, which is subtracted from the Fair Market Value in determining the amount payable to a Participant upon exercise of such SAR.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the market price of a Share, determined by the Committee as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;If the Shares are traded on a stock exchange (such as the New York Stock Exchange, NYSE MKT, the NASDAQ Global Market or NASDAQ Capital Market) at the time of determination, then the Fair Market Value shall be equal to the regular session closing price for such stock as reported by such exchange (or the exchange or market with the greatest volume of trading in the Shares) on the date of determination, or if there are no sales on such date, on the last date preceding such date on which a closing price was reported&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If the Shares are traded on the OTC Bulletin Board at the time of determination, then the Fair Market Value shall be equal to the last-sale price reported by the OTC Bulletin Board for such date, or if there are no sales on such date, on the last date preceding such date on which a sale was reported&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;If neither of the foregoing provisions is applicable, then the Fair Market Value shall be determined by the Committee in good faith using a reasonable application of a reasonable valuation method as the Committee deems appropriate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever possible, the determination of Fair Market Value by the Committee shall be based on the prices reported by the applicable exchange or the OTC Bulletin Board, as applicable, or a nationally recognized publisher of stock prices or quotations (including an electronic on-line publication). Such determination shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s fiscal year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ISO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an incentive stock option described in Code Section 422.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, to the extent that a Stock Option Agreement so provides and as permitted by applicable law, an arrangement pursuant to which the number of Shares issued to the Optionee in connection with the Optionee&#8217;s exercise of the Option will be reduced by the Company&#8217;s retention of a portion of such Shares. Upon such a net exercise of an Option, the Optionee will receive a net number of Shares that is equal to (i) the number of Shares as to which the Option is being exercised minus (ii) the quotient (rounded down to the nearest whole number) of the aggregate Exercise Price of the Shares being exercised divided by the Fair Market Value of a Share on the Option exercise date. The number of Shares covered by clause (ii) will be retained by the Company and not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivered to the Optionee. No fractional Shares will be created as a result of a Net Exercise and the Optionee must contemporaneously pay for any portion of the aggregate Exercise Price that is not covered by the Shares retained by the Company under clause (ii). The number of Shares delivered to the Optionee may be further reduced if Net Exercise is utilized under Section 14(b) to satisfy applicable tax withholding obligations.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board who is not an Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NSO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a stock option that is not an ISO.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual who is an officer of the Company within the meaning of Rule 16a-1(f) of the Exchange Act.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an ISO or NSO granted under the Plan entitling the Optionee to purchase a specified number of Shares, at such times and applying a specified Exercise Price, as provided in the applicable Stock Option Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual, estate or other entity that holds an Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the Adoption Date shall be considered a Parent commencing as of such date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual or estate or other entity that holds an Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means one or more objective performance targets established for a Participant which may be described in terms of Company-wide objectives and&#47;or objectives that are related to the performance of the individual Participant or a Parent, Subsidiary, Affiliate, division, department or function within the Company or entity in which the Participant is employed, and such targets may be applied either individually, alternatively or in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years&#8217; results or to a designated comparison group, in each case as specified by the Committee. Any Performance Goals that are included in an Award in order to make such Award qualify as performance-based compensation under Code Section 162(m) shall be limited to one or more of the following target objectives&#58; (i) operating income&#59; (ii) earnings before interest, taxes, depreciation and amortization, or EBITDA&#59; (iii) earnings&#59; (iv) cash flow&#59; (v) market share&#59; (vi) sales or revenue, including with respect to a particular product, business line, geography or market&#59; (vii) expenses&#59; (viii) cost of goods sold&#59; (ix) profit&#47;loss or profit margin&#59; (x) working capital&#59; (xi) return on equity or assets or investment&#59; (xii) earnings per share&#59; (xiii) economic value added, or EVA&#59; (xiv) stock price including without limitation total stockholder return&#59; (xv) price&#47;earnings ratio&#59; (xvi) debt or debt-to-equity&#59; (xvii) accounts receivable&#59; (xviii) writeoffs&#59; (xix) cash&#59; (xx) assets&#59; (xxi) liquidity&#59; (xxii) operations&#59; (xxiii) research or related milestones&#59; (xxiv) business development&#59; (xxv) intellectual property (e.g., patents)&#59; (xxvi) product development&#59; (xxvii) regulatory activity&#59; (xxviii) information technology&#59; (xxix) financings&#59; (xxx) product quality control&#59; (xxxi) management&#59; (xxxii) human resources&#59; (xxxiii) corporate governance&#59; (xxxiv) compliance program&#59; (xxxv) legal matters&#59; (xxxvi) internal controls&#59; (xxxvii) policies and procedures&#59; (xxxviii) accounting and reporting&#59; (xxxix) strategic alliances, licensing and partnering&#59; (xl) site, plant or building development&#59; (xli) corporate transactions including without limitation mergers, acquisitions, divestitures and&#47;or joint ventures&#59; (xlii) customer satisfaction&#59; (xliii) capital expenditures and&#47;or (xliv) Company advancement milestones. Awards issued to individuals who are not Covered Employees (or which are not intended to qualify as performance-based compensation under Code Section 162(m)) may take into account other (or no) factors.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any period of time as determined by the Committee, in its sole discretion. The Committee may establish different Performance Periods for different Participants, and the Committee may establish concurrent or overlapping Performance Periods.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this LifeVantage Corporation 2017 Long-Term Incentive Plan as it may be amended from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Equity Compensation Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s 2010 Long-Term Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2010 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), 2007 Long-Term Incentive Plan (as assumed from Lifeline Therapeutics, Inc., a Colorado corporation) and its predecessor plans and any other Company equity compensation plans.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Re-Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means that the Company has lowered or reduced the Exercise Price of outstanding Options and&#47;or outstanding SARs for any Participant(s) in a manner described by SEC Regulation S-K Item 402(d)(2)(viii) (or as described in any successor provision(s) or definition(s)).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Shares awarded under the Plan as provided in Section 9.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Grant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section 9 evidencing each Award of a Restricted Stock Grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section 8 evidencing each Award of a Stock Appreciation Right.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities and Exchange Commission.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pp)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those officers, directors or other persons who are subject to Section 16 of the Exchange Act.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(qq)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(rr)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selected Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee, Consultant, Director, or Non-Employee Director who has been selected by the Committee to receive an Award under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ss)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation From Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Participant&#8217;s separation from service with the Company within the meaning provided to such term under Code Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(tt)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means service as an Employee, Director, Non-Employee Director or Consultant. Service will be deemed terminated as soon as the entity to which Service is being provided is no longer either (i) the Company, (ii) a Parent, (iii) a Subsidiary or (iv) an Affiliate. A Participant&#8217;s Service does not terminate if he or she is a common-law employee with respect to the Company, a Parent, a Subsidiary or an Affiliate and goes on a bona fide leave of absence that was approved by the Company in writing and the terms of the leave provide for continued service crediting, or when continued service crediting is required by applicable law. However, for purposes of determining whether an Option is entitled to continuing ISO status, a common-law employee&#8217;s Service will be treated as terminating ninety (90) days after such Employee went on leave, unless such Employee&#8217;s right to return to active work is guaranteed by law or by a contract. Service terminates in any event when the approved leave ends, unless such Employee immediately returns to active work. The Committee determines which leaves count toward Service, and when Service commences and terminates for all purposes under the Plan. For avoidance of doubt, a Participant&#8217;s Service shall not be deemed terminated if the Committee determines that (i) a transition of employment to service with a partnership, joint venture or corporation not meeting the requirements of a Subsidiary in which the Company or a Subsidiary is a party is not considered a termination of Service, (ii) the Participant transfers between service as an Employee and service as a Consultant or other personal service provider (or vice versa), or (iii) the Participant transfers between service as an Employee and that of a Non-Employee Director (or vice versa). The Committee may determine whether any company transaction, such as a sale or spin-off of a division or subsidiary that employs a Participant, shall be deemed to result in termination of Service for purposes of any affected Awards, and the Committee&#8217;s decision shall be final and binding.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(uu)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means one share of Common Stock.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vv)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Approval Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that the Company&#8217;s stockholders approve this Plan provided that such approval must occur on or before the first anniversary of the Adoption Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ww)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Participant who is considered a &#8220;specified employee&#8221; within the meaning provided to such term under Code Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xx)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a stock appreciation right awarded under the Plan which provides the holder with a right to potentially receive, in cash and&#47;or Shares, value with respect to a specific number of Shares, as provided in Section 8.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(yy)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section 6 evidencing each Award of an Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(zz)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a bookkeeping entry representing the equivalent of one Share, as awarded under the Plan and as provided in Section 10.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aaa)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section 10 evidencing each Award of Stock Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bbb)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the Adoption Date shall be considered a Subsidiary commencing as of such date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ccc)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date on which a Participant&#8217;s Service terminates as determined by the Committee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ddd)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10-Percent Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Section 424(d) of the Code shall be applied.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 3.  ADMINISTRATION</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee Composition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Committee appointed by the Board shall administer the Plan. Unless the Board provides otherwise, the Board&#8217;s Compensation Committee (or a comparable committee of the Board) shall be the Committee. The Board may also at any time terminate the functions of the Committee and reassume all powers and authority previously delegated to the Committee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent required, the Committee shall have membership composition which enables (i) Awards to Section 16 Persons to qualify as exempt from liability under Section 16(b) of the Exchange Act and (ii) Awards to Covered Employees to be able to qualify as performance-based compensation as provided under Code Section 162(m) (to the extent such Awards are intended to qualify as performance-based compensation).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may also appoint one or more separate committees of the Board, each composed of directors of the Company who need not qualify under Rule 16b-3 of the Exchange Act or Code Section 162(m), that may administer the Plan with respect to Selected Employees who are not Section 16 Persons or Covered Employees, respectively, may grant Awards under the Plan to such Selected Employees and may determine all terms of such Awards. To the extent permitted by applicable law, the Board may also appoint a committee, composed of one or more Officers, that may authorize Awards to Employees (who are not Section 16 Persons or Covered Employees) within parameters specified by the Board and consistent with any limitations imposed by applicable law.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall comply with rules and regulations applicable to it, including under the rules of any exchange on which the Shares are traded.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Board shall constitute the Committee and shall administer the Plan with respect to all Awards granted to Non-Employee Directors.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Authority of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the provisions of the Plan, the Committee shall have full authority and discretion to take any actions it deems necessary or advisable for the administration of the Plan. Such actions shall include without limitation&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;determining Selected Employees who are to receive Awards under the Plan&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;determining the type, number, vesting requirements, Performance Goals (if any) and their degree of satisfaction, and other features and conditions of such Awards and amending such Awards&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;correcting any defect, supplying any omission, or reconciling or clarifying any inconsistency in the Plan or any Award Agreement&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;accelerating the vesting, or extending the post-termination exercise term, or waiving restrictions, of Awards at any time and under such terms and conditions as it deems appropriate&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;interpreting the Plan and any Award Agreements&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;making all other decisions relating to the operation of the Plan&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;adopting such plans or subplans as may be deemed necessary or appropriate to provide for the participation by non-U.S. employees of the Company and its Subsidiaries and Affiliates, which plans and&#47;or subplans shall be attached hereto as appendices.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee may adopt such rules or guidelines, as it deems appropriate to implement the Plan. The Committee&#8217;s determinations under the Plan shall be final, conclusive and binding on all persons. The Committee&#8217;s decisions and determinations need not be uniform and may be made selectively among Participants in the Committee&#8217;s sole discretion. The Committee&#8217;s decisions and determinations will be afforded the maximum deference provided by applicable law.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the maximum extent permitted by applicable law, each member of the Committee, or of the Board, or any persons (including without limitation Employees and Officers) who are delegated by the Board or Committee to perform oversight or administrative functions in connection with the Plan, shall be indemnified and held harmless by the Company against and from (i) any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan or any Award Agreement, and (ii) from any and all amounts paid by him or her in settlement thereof, with the Company&#8217;s approval, or paid by him or her in satisfaction of any judgment in any such claim, action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company&#8217;s Articles of Incorporation or Bylaws, by contract, as a matter of law, or otherwise, or under any power that the Company may have to indemnify them or hold them harmless.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 4.  GENERAL</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Only Employees, Consultants, Directors and Non-Employee Directors shall be eligible for designation as Selected Employees by the Committee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Only Selected Employees who are common-law employees of the Company, a Parent or a Subsidiary shall be eligible for the grant of ISOs. In addition, a Selected Employee who is a 10-Percent Stockholder shall not be eligible for the grant of an ISO unless the requirements set forth in Section 422(c)(5) of the Code are satisfied. If and to the extent that any Shares are issued under a portion of any Option that exceeds the $100,000 limitation of Section 422 of the Code, such Shares shall not be treated as issued under an ISO notwithstanding any designation otherwise. Certain decisions, amendments, interpretations and actions by the Committee and certain actions by a Participant may cause an Option to cease to qualify as an ISO pursuant to the Code and by accepting an Option the Participant agrees in advance to such disqualifying action.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictions on Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any Shares issued pursuant to an Award shall be subject to such Company policies, rights of repurchase, rights of first refusal and other transfer restrictions as the Committee may determine. Such restrictions shall apply in addition to any restrictions that may apply to holders of Shares generally and shall also comply to the extent necessary with applicable law. In no event shall the Company be required to issue fractional Shares under this Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may designate one or more beneficiaries with respect to an Award by timely filing the prescribed form with the Company. A beneficiary designation may be changed by filing the prescribed form with the Company at any time before the Participant&#8217;s death. If no beneficiary was designated or if no designated beneficiary survives the Participant, then after a Participant&#8217;s death any vested Award(s) shall be transferred or distributed to the Participant&#8217;s estate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Committee may, in its discretion, include Performance Goals or other performance objectives in any Award. If Performance Goals are included in Awards to Covered Employees in order to enable such Awards to qualify as performance-based compensation under Code Section 162(m), then such Awards will be subject to the achievement of such Performance Goals that will be established and administered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuant to the requirements of Code Section 162(m) and as described in this Section 4(e). If an Award is intended to qualify as performance-based compensation under Code Section 162(m) and to the extent required by Code Section 162(m), the Committee shall certify in writing the degree to which the Performance Goals have been satisfied before any Shares underlying an Award or any Award payments are released to a Covered Employee with respect to a Performance Period. Without limitation, the approved minutes of a Committee meeting shall constitute such written certification. With respect to Awards that are intended to qualify as performance-based compensation under Code Section 162(m), the Committee may adjust the evaluation of performance under a Performance Goal (to the extent permitted by Code Section 162(m)) to remove the effects of certain events including without limitation the following&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;asset write-downs or discontinued operations,</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;litigation or claim judgments or settlements,</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;material changes in or provisions under tax law, accounting principles or other such laws or provisions affecting reported results,</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;reorganizations or restructuring programs or divestitures or acquisitions, and&#47;or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;extraordinary non-recurring items as described in applicable accounting principles and&#47;or items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding satisfaction of any completion of any Performance Goal, to the extent specified at the time of grant of an Award, the number of Shares, Options, SARs, Stock Units or other benefits granted, issued, retainable and&#47;or vested under an Award on account of satisfaction of such Performance Goals may be reduced by the Committee on the basis of such further considerations as the Committee in its sole discretion shall determine. Awards with Performance Goals or performance objectives (if any) that are granted to Selected Employees who are not Covered Employees or any Awards to Covered Employees which are not intended to qualify as performance-based compensation under Code Section 162(m) need not comply with the requirements of Code Section 162(m).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant, or a transferee of a Participant, shall have no rights as a stockholder (including without limitation voting rights or dividend or distribution rights) with respect to any Common Stock covered by an Award until such person becomes entitled to receive such Common Stock, has satisfied any applicable withholding or tax obligations relating to the Award and the Common Stock has been issued to the Participant. No adjustment shall be made for cash or stock dividends or other rights for which the record date is prior to the date when such Common Stock is issued, except as expressly provided in Section 11. For the avoidance of doubt, no Award shall allow for the payment of dividends with respect to any portion of the Award that does not vest or as to which applicable vesting or performance conditions are not satisfied.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless the applicable Award Agreement or employment agreement provides otherwise (and in such case, the Award or employment agreement shall govern as to the consequences of a termination of Service for such Awards), the following rules shall govern the vesting, exercisability and term of outstanding Awards held by a Participant in the event of termination of such Participant&#8217;s Service (in all cases subject to the term of the Option or SAR as applicable)&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;if the Service of a Participant is terminated for Cause, then all of the Participant&#8217;s Options, SARs, unvested portions of Stock Units and unvested portions of Restricted Stock Grants shall terminate and be forfeited immediately without consideration as of the Termination Date (except for repayment of any amounts the Participant had previously paid to the Company to acquire Shares underlying the forfeited Awards)&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if the Service of Participant is terminated for any reason other than for Cause and other due to the Participant&#8217;s death or Disability, then the vested portion of the Participant&#8217;s then-outstanding Options&#47;SARs may be exercised by such Participant or his or her personal representative within three months after the Termination Date and all unvested portions of the Participant&#8217;s outstanding Awards shall be forfeited without consideration as of the Termination Date (except for repayment of any amounts the Participant had previously paid to the Company to acquire Shares underlying the forfeited Awards)&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;if the Service of a Participant is terminated due to the Participant&#8217;s death or Disability, the vested portion of the Participant&#8217;s then outstanding Options&#47;SARs may be exercised within twelve months after </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Termination Date and all unvested portions of any outstanding Awards shall be forfeited without consideration as of the Termination Date (except for repayment of any amounts the Participant had previously paid to the Company to acquire Shares underlying the forfeited Awards).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything in the Plan to the contrary, the Plan and Awards granted hereunder are intended to comply with the requirements of Code Section 409A and shall be interpreted in a manner consistent with such intention. In the event that any provision of the Plan or an Award Agreement is determined by the Committee to not comply with the applicable requirements of Code Section 409A and the Treasury Regulations and other guidance issued thereunder, the Committee shall have the authority to take such actions and to make such changes to the Plan or an Award Agreement as the Committee deems necessary to comply with such requirements, provided that no such action shall adversely affect any outstanding Award without the consent of the affected Participant. Each payment to a Participant made pursuant to this Plan shall be considered a separate payment and not one of a series of payments for purposes of Code Section 409A. Notwithstanding the foregoing or anything elsewhere in the Plan or an Award Agreement to the contrary, if upon a Participant&#8217;s Separation From Service he&#47;she is then a Specified Employee, then solely to the extent necessary to comply with Code Section 409A and avoid the imposition of taxes under Code Section 409A, the Company shall defer payment of &#8220;nonqualified deferred compensation&#8221; subject to Code Section 409A payable as a result of and within six (6) months following such Separation From Service under this Plan until the earlier of (i) the first business day of the seventh month following the Participant&#8217;s Separation From Service, or (ii) ten (10) days after the Company receives written confirmation of the Participant&#8217;s death. Any such delayed payments shall be made without interest. In no event whatsoever shall the Company be liable for any additional tax, interest or penalties that may be imposed on a Participant by Code Section 409A or for any damages for failing to comply with Code Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Suspension or Termination of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If at any time (including after a notice of exercise has been delivered) the Committee (or the Board), reasonably believes that a Participant has committed an act of Cause (which includes a failure to act), the Committee (or Board) may suspend the Participant&#8217;s right to exercise any Option or SAR (or payment of a Cash Award or vesting of Restricted Stock Grants or Stock Units) pending a determination of whether there was in fact an act of Cause. If the Committee (or the Board) determines a Participant has committed an act of Cause, neither the Participant nor his or her estate shall be entitled to exercise any outstanding Option or SAR whatsoever and all of Participant&#8217;s outstanding Awards shall then terminate without consideration. Any determination by the Committee (or the Board) with respect to the foregoing shall be final, conclusive and binding on all interested parties.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to compliance with applicable law and&#47;or regulations, an Award Agreement or other documentation or notices relating to the Plan and&#47;or Awards may be communicated to Participants by electronic media.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unfunded Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Insofar as it provides for Awards, the Plan shall be unfunded. Although bookkeeping accounts may be established with respect to Participants who are granted Awards under this Plan, any such accounts will be used merely as a bookkeeping convenience. The Company shall not be required to segregate any assets which may at any time be represented by Awards, nor shall this Plan be construed as providing for such segregation, nor shall the Company or the Committee be deemed to be a trustee of stock or cash to be awarded under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liability of Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company (or members of the Board or Committee) shall not be liable to a Participant or other persons as to&#58; (a) the non-issuance or sale of Shares as to which the Company has been unable to obtain from any regulatory body having jurisdiction the authority deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder&#59; and (b) any unexpected or adverse tax consequence or any tax consequence expected, but not realized, by any Participant or other person due to the grant, receipt, exercise or settlement of any Award granted hereunder.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reformation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event any provision of this Plan shall be held illegal or invalid for any reason, such provisions will be reformed by the Board if possible and to the extent needed in order to be held legal and valid. If it is not possible to reform the illegal or invalid provisions then the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Re-Pricing of Options or SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary, without the approval of Company stockholders and except as provided in Section 11(a), outstanding Options or SARs may not be re-priced, replaced or regranted (i) through cancellation, whether in exchange for cash or another type of Award, (ii) by lowering the Exercise Price of a previously granted Option or SAR or (iii) by replacing a previously granted Option or SAR with a new Option or SAR with a lower Exercise Price.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any reference to a statute, rule or regulation, or to a section of a statute, rule or regulation, is a reference to that statute, rule, regulation, or section as amended from time to time, both before and after the Adoption Date and including any successor provisions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Plan and all Awards shall be construed in accordance with and governed by the laws of the State of Utah but without regard to its conflict of law provisions. The Committee may provide that any dispute as to any Award shall be presented and determined in such forum as the Committee may specify, including through binding arbitration. Unless otherwise provided in the Award Agreement, recipients of an Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of Utah to resolve any and all issues that may arise out of or relate to the Plan or any related Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Minimum Vesting Requirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No Award granted on or after July 1, 2018 shall vest, become exercisable or be settled on a date that is earlier than the first anniversary of the grant date of the Award&#59; provided however that this minimum vesting and exercisability requirement shall not apply (i) to up to 5% of the aggregate number of shares reserved for issuance hereunder, (ii) if Section 12 applies, or (iii) with respect to an Award held by a Participant whose Service terminates as a result of his or her death or disability. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 5.  SHARES SUBJECT TO PLAN AND SHARE LIMITS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basic Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Common Stock issuable under the Plan shall be authorized but unissued Shares or treasury Shares.  Subject to adjustment as provided in Section 11, the maximum aggregate number of Shares that may be issued under the Plan shall not exceed the sum of (i) 2,440,000 Shares, (ii) the number of Shares reserved under the 2010 Plan that are not issued or subject to outstanding awards under the 2010 Plan on the Stockholder Approval Date, (iii) any Shares subject to outstanding options or other awards under the 2010 Plan on the Stockholder Approval Date that subsequently expire or lapse unexercised and Shares issued pursuant to awards granted under the 2010 Plan that are outstanding on the Stockholder Approval Date and that are subsequently forfeited to or repurchased by the Company, and (iv) the additional Shares described in Section 5(b)&#59; provided, however, that no more than 475,000 Shares, in the aggregate, shall be added to the Plan pursuant to clauses (ii) and (iii).  No more than 2,915,000 Shares plus the additional Shares described in Section 5(b) may be issued under the Plan upon the exercise of ISOs.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share Re-Use</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Equity Awards are forfeited or are terminated for any reason other than being exercised, then the Shares underlying such Equity Awards shall again become available for Equity Awards under the Plan. If SARs are exercised or Stock Units are settled in Shares, then only the number of Shares (if any) actually issued in settlement of such SARs or Stock Units shall reduce the number of Shares available under the Share limits stated in Section 5(a) and the balance shall again become available for Equity Awards under the Plan. If a Participant pays the Exercise Price by Net Exercise or by surrendering previously owned Shares (or by stock attestation) and&#47;or, as permitted by the Committee, pays any withholding tax obligation with respect to an Equity Award by electing to have Shares withheld or surrendering previously owned Shares (or by stock attestation), the surrendered Shares and the Shares withheld to pay taxes shall be available for issuance under the Plan and shall not count toward the Share limits set forth in Section 5(a). Any Shares that are delivered and any Equity Awards that are granted by, or become obligations of, the Company, as a result of the assumption by the Company of, or in substitution for, outstanding awards previously granted by another entity (as provided in Sections 6(e), 8(f), 9(e) or 10(e)) shall not be counted against the Share limits specified in Sections 5(a) and 5(d).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any dividend equivalents distributed under the Plan shall not be applied against the number of Shares available for Equity Awards.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 162(m) Limits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For so long as&#58; (x) the Company is a &#8220;publicly held corporation&#8221; within the meaning of Code Section 162(m) and (y) the deduction limitations of Code Section 162(m) are applicable to Awards granted to the Company&#8217;s Covered Employees under this Plan, then the limits specified below in this Section 5(d) shall be applicable to Awards issued under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limits on Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Selected Employee shall receive Options to purchase Shares during any Fiscal Year that in the aggregate cover in excess of 300,000 Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limits on SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Selected Employee shall receive Awards of SARs during any Fiscal Year that in the aggregate cover in excess of 300,000 Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limits on Restricted Stock Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Selected Employee shall receive Restricted Stock Grants during any Fiscal Year that in the aggregate cover in excess of 300,000 Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limits on Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Selected Employee shall receive Stock Units during any Fiscal Year that in the aggregate cover in excess of 300,000 Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limit on Total Amount of All Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained herein, no Selected Employee shall receive Equity Awards during any Fiscal Year in excess of the aggregate amount of 600,000 Shares, whether such Equity Awards are in the form of Options, SARs, Restricted Stock Grants and&#47;or Stock Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Increased Limits for First Year of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The numerical limits expressed in the foregoing subparts (i) through (iv) shall in each case be increased to 600,000 Shares with respect to Equity Awards granted to a Selected Employee during the Fiscal Year of the Selected Employee&#8217;s commencement of employment with the Company or during the first Fiscal Year that the Selected Employee becomes a Covered Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dollar Limit for Cash Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The maximum aggregate value of Cash Awards that may be received by any one Selected Employee with respect to any individual Fiscal Year is $5,000,000.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 6.  TERMS AND CONDITIONS OF OPTIONS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Award of an Option under the Plan shall be evidenced by a Stock Option Agreement between the Optionee and the Company. Such Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan (including without limitation any Performance Goals). The provisions of the various Stock Option Agreements entered into under the Plan need not be identical. The Stock Option Agreement shall also specify whether the Option is an ISO and if not specified then the Option shall be an NSO.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Stock Option Agreement shall specify the number of Shares that are subject to the Option and is subject to adjustment of such number in accordance with Section 11.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option&#8217;s Exercise Price shall be established by the Committee and set forth in a Stock Option Agreement. Except with respect to outstanding stock options being assumed or Options being granted in exchange for cancellation of outstanding options granted by another issuer as provided under Section 6(e), the Exercise Price of an Option shall not be less than 100% of the Fair Market Value (110% for ISO Awards to 10-Percent Stockholders) on the date of Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercisability and Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Stock Option Agreement shall specify the date when all or any installment of the Option is to become vested and&#47;or exercisable. The Stock Option Agreement shall also specify the term of the Option&#59; provided that the term of an Option shall in no event exceed ten years from the date of Award (and may be for a shorter period of time than ten years). No Option can be exercised after the expiration date specified in the applicable Stock Option Agreement. A Stock Option Agreement may provide for accelerated vesting in the event of the Participant&#8217;s death, or Disability or other events. Notwithstanding the previous sentence, an ISO that is granted to a 10-Percent Stockholder shall have a maximum term of five years. Notwithstanding any other provision of the Plan, no Option can be exercised after the expiration date provided in the applicable Stock Option Agreement. In no event shall the Company be required to issue fractional Shares upon the exercise of an Option and the Committee may specify a minimum number of Shares that must be purchased in any one Option exercise.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modifications or Assumption of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify, extend or assume outstanding Options or may accept the cancellation of outstanding stock options (whether granted by the Company or by another issuer) in return for the grant of new Options for the same or a different number of Shares and at the same or a different Exercise Price. For avoidance of doubt, in accordance with Section 4(n), the Committee may not Re-Price outstanding Options without approval from the Company's stockholders, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">except as provided in Section 11(a). No modification of an Option shall, without the consent of the Optionee, impair his or her rights or increase his or her obligations under such Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment or Transfer of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise provided in the applicable Stock Option Agreement and then only to the extent permitted by applicable law, no Option shall be transferable by the Optionee other than by will or by the laws of descent and distribution. Except as otherwise provided in the applicable Stock Option Agreement, an Option may be exercised during the lifetime of the Optionee only by Optionee or by the guardian or legal representative of the Optionee. No Option or interest therein may be assigned, pledged or hypothecated by the Optionee during his or her lifetime, whether by operation of law or otherwise, or be made subject to execution, attachment or similar process.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 7.  PAYMENT FOR OPTION SHARES</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The entire Exercise Price of Shares issued upon exercise of Options shall be payable in cash at the time when such Shares are purchased by the Optionee, except as follows and if so provided for in an applicable Stock Option Agreement&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;In the case of an ISO granted under the Plan, payment shall be made only pursuant to the express provisions of the applicable Stock Option Agreement. The Stock Option Agreement may specify that payment may be made in any form(s) described in this Section 7.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;In the case of an NSO granted under the Plan, the Committee may, in its discretion at any time, accept payment in any form(s) described in this Section 7.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Surrender of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent that the Committee makes this Section 7(b) applicable to an Option in a Stock Option Agreement, payment for all or a part of the Exercise Price may be made with Shares which have already been owned by the Optionee for such duration as shall be specified by the Committee. Such Shares shall be valued at their Fair Market Value on the date when the new Shares are purchased under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent that the Committee makes this Section 7(c) applicable to an Option in a Stock Option Agreement, payment for all or a part of the Exercise Price may be made through Cashless Exercise.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent that the Committee makes this Section 7(d) applicable to an Option in a Stock Option Agreement, payment for all or a part of the Exercise Price may be made through Net Exercise.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Forms of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent that the Committee makes this Section 7(e) applicable to an Option in a Stock Option Agreement, payment may be made in any other form that is consistent with applicable laws, regulations and rules and approved by the Committee.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 8.  TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Award of a SAR under the Plan shall be evidenced by a SAR Agreement between the Participant and the Company. Such SAR shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan (including without limitation any Performance Goals). A SAR Agreement may provide for a maximum limit on the amount of any payout notwithstanding the Fair Market Value on the date of exercise of the SAR. The provisions of the various SAR Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each SAR Agreement shall specify the number of Shares to which the SAR pertains and is subject to adjustment of such number in accordance with Section 11.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each SAR Agreement shall specify the Exercise Price. Except with respect to outstanding stock appreciation rights being assumed or SARs being granted in exchange for cancellation of outstanding stock appreciation rights granted by another issuer as provided under Section 8(f), the Exercise Price of a SAR shall not be less than 100% of the Fair Market Value on the date of Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercisability and Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each SAR Agreement shall specify the date when all or any installment of the SAR is to become exercisable. The SAR Agreement shall also specify the term of the SAR which shall not exceed ten years from the date of Award. No SAR can be exercised after the expiration date specified in the applicable SAR Agreement. A SAR Agreement may provide for accelerated exercisability in the event of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant&#8217;s death, or Disability or other events and may provide for expiration prior to the end of its term in the event of the termination of the Participant&#8217;s Service. A SAR may be included in an ISO only at the time of Award but may be included in an NSO at the time of Award or at any subsequent time, but not later than six months before the expiration of such NSO. A SAR granted under the Plan may provide that it will be exercisable only in the event of a Change in Control.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If, on the date when a SAR expires, the Exercise Price under such SAR is less than the Fair Market Value on such date but any portion of such SAR has not been exercised or surrendered, then such SAR may automatically be deemed to be exercised as of such date with respect to such portion to the extent so provided in the applicable SAR agreement. Upon exercise of a SAR, the Participant (or any person having the right to exercise the SAR after the Participant&#8217;s death) shall receive from the Company (i) Shares, (ii) cash or (iii) any combination of Shares and cash, as the Committee shall determine. The amount of cash and&#47;or the Fair Market Value of Shares received upon exercise of SARs shall, in the aggregate, be equal to the amount by which the Fair Market Value (on the date of surrender) of the Shares subject to the SARs exceeds the Exercise Price of the Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modification or Assumption of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify, extend or assume outstanding SARs or may accept the cancellation of outstanding SARs (including stock appreciation rights granted by another issuer) in return for the grant of new SARs for the same or a different number of Shares and at the same or a different Exercise Price.  For avoidance of doubt, in accordance with Section 4(n), the Committee may not Re-Price outstanding SARs without approval from the Company's stockholders, except as provided in Section 11(a).  No modification of a SAR shall, without the consent of the Participant, impair his or her rights or increase his or her obligations under such SAR.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment or Transfer of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise provided in the applicable SAR Agreement and then only to the extent permitted by applicable law, no SAR shall be transferable by the Participant other than by will or by the laws of descent and distribution. Except as otherwise provided in the applicable SAR Agreement, a SAR may be exercised during the lifetime of the Participant only by the Participant or by the guardian or legal representative of the Participant. No SAR or interest therein may be assigned, pledged or hypothecated by the Participant during his or her lifetime, whether by operation of law or otherwise, or be made subject to execution, attachment or similar process.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 9.  TERMS AND CONDITIONS FOR RESTRICTED STOCK GRANTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Grant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Grant awarded under the Plan shall be evidenced by a Restricted Stock Grant Agreement between the Participant and the Company. Each Restricted Stock Grant shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan (including without limitation any Performance Goals). The provisions of the Restricted Stock Grant Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Grant Agreement shall specify the number of Shares to which the Restricted Stock Grant pertains and is subject to adjustment of such number in accordance with Section 11. Restricted Stock Grants may be issued with or without cash consideration under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Grant may or may not be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Restricted Stock Grant Agreement. A Restricted Stock Grant Agreement may provide for accelerated vesting in the event of the Participant&#8217;s death, or Disability or other events.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The holder of a Restricted Stock Grant (irrespective of whether the Shares subject to the Restricted Stock Grant are vested or unvested) awarded under the Plan shall have the same voting, dividend and other rights as the Company's other stockholders&#59; provided however that any dividends attributed to Shares that are unvested (whether such dividends are in the form of cash or Shares) shall be subject to the same vesting conditions and restrictions as the Restricted Stock Grant with respect to which the dividends relate&#59; and provided further that this sentence is subject to the final sentence of Section 4(f). Such additional Shares issued as dividends that are subject to the Restricted Stock Grant shall not reduce the number of Shares available for issuance under Section 5.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modification or Assumption of Restricted Stock Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify or assume outstanding Restricted Stock Grants or may accept the cancellation of outstanding Restricted Stock Grants (including stock granted by another issuer) in return for the grant of new Restricted Stock Grants for the same or a different number of Shares. No modification of a Restricted Stock Grant shall, without the consent of the Participant, impair his or her rights or increase his or her obligations under such Restricted Stock Grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment or Transfer of Restricted Stock Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in Section 14, or in a Restricted Stock Grant Agreement, or as required by applicable law, a Restricted Stock Grant awarded under the Plan shall not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor's process, whether voluntarily, involuntarily or by operation of law. Any act in violation of this Section 9(f) shall be void. However, this Section 9(f) shall not preclude a Participant from designating a beneficiary pursuant to Section 4(d) nor shall it preclude a transfer of Restricted Stock Grant Awards by will or pursuant to Section 4(d).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 10.  TERMS AND CONDITIONS OF STOCK UNITS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Award of Stock Units under the Plan shall be evidenced by a Stock Unit Agreement between the Participant and the Company. Such Stock Units shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan (including without limitation any Performance Goals). The provisions of the various Stock Unit Agreements entered into under the Plan need not be identical.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Stock Unit Agreement shall specify the number of Shares to which the Stock Unit Grant pertains and is subject to adjustment of such number in accordance with Section 11. To the extent that an Award is granted in the form of Stock Units, no cash consideration shall be required of the Award recipients.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Award of Stock Units may or may not be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Stock Unit Agreement. A Stock Unit Agreement may provide for accelerated vesting in the event of the Participant&#8217;s death, or Disability or other events.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The holders of Stock Units shall have no voting rights. Prior to settlement or forfeiture, any Stock Unit awarded under the Plan may, at the Committee&#8217;s discretion, carry with it a right to dividend equivalents. Such right entitles the holder to be credited with an amount equal to all cash or Common Stock dividends paid on one Share while the Stock Unit is outstanding. Dividend equivalents may be converted into additional Stock Units. Settlement of dividend equivalents may be made in the form of cash, in the form of Shares, or in a combination of both. Prior to vesting of the Stock Units, any dividend equivalents accrued on such unvested Stock Units shall be subject to the same vesting conditions and restrictions as the Stock Units to which they attach, provided that this sentence is subject to the final sentence of Section 4(f).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modification or Assumption of Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within the limitations of the Plan, the Committee may modify or assume outstanding Stock Units or may accept the cancellation of outstanding Stock Units (including stock units granted by another issuer) in return for the grant of new Stock Units for the same or a different number of Shares. No modification of a Stock Unit shall, without the consent of the Participant, impair his or her rights or increase his or her obligations under such Stock Unit.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment or Transfer of Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in Section 14, or in a Stock Unit Agreement, or as required by applicable law, Stock Units shall not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor&#8217;s process, whether voluntarily, involuntarily or by operation of law. Any act in violation of this Section 10(f) shall be void. However, this Section 10(f) shall not preclude a Participant from designating a beneficiary pursuant to Section 4(d) nor shall it preclude a transfer of Stock Units pursuant to Section 4(d).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Time of Settlement of Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Settlement of vested Stock Units may be made in the form of (a) cash, (b) Shares or (c) any combination of both, as determined by the Committee. The actual number of Stock Units eligible for settlement may be larger or smaller than the number included in the original Award. Methods of converting Stock Units into cash may include (without limitation) a method based on the average Fair </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market Value of Shares over a series of trading days. Except as otherwise provided in a Stock Unit Agreement or a timely completed deferral election, vested Stock Units shall be settled within thirty days after vesting. The distribution may occur or commence when all vesting conditions applicable to the Stock Units have been satisfied or have lapsed, or it may be deferred, in accordance with applicable law, to a later specified date. The amount of a deferred distribution may be increased by an interest factor or by dividend equivalents. Until an Award of Stock Units is settled, the number of such Stock Units shall be subject to adjustment pursuant to Section 11.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Creditors' Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A holder of Stock Units shall have no rights other than those of a general creditor of the Company. Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Stock Unit Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 11.        ADJUSTMENTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a subdivision of the outstanding Shares, a declaration of a dividend payable in Shares, a declaration of a dividend payable in a form other than Shares in an amount that has a material effect on the price of Shares, a combination or consolidation of the outstanding Shares (by reclassification or otherwise) into a lesser number of Shares, a stock split, a reverse stock split, a reclassification or other distribution of the Shares without the receipt of consideration by the Company, of or on the Common Stock, a recapitalization, a combination, a spin-off or a similar occurrence, the Committee shall make equitable and proportionate adjustments to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the number and kind of securities available for Equity Awards (and which can be issued as ISOs) under Section 5&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Share limits on Equity Awards issued under the Plan that are intended to qualify as performance-based compensation under Code Section 162(m) under Section 5(d)&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the number and kind of securities covered by each outstanding Equity Award&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;the Exercise Price under each outstanding SAR and Option, and the repurchase price, if any, applicable to the unvested portion of Restricted Stock Grants&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;the number and kind of outstanding securities issued under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in this Section 11, a Participant shall have no rights by reason of any issue by the Company of stock of any class or securities convertible into stock of any class, any subdivision or consolidation of shares of stock of any class, the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class. If by reason of an adjustment pursuant to this Section 11, a Participant&#8217;s Equity Award covers additional or different shares of stock or securities, then such additional or different shares and the Equity Award in respect thereof shall be subject to all of the terms, conditions and restrictions which were applicable to the Equity Award and the Shares subject to the Equity Award prior to such adjustment.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any adjustment of Shares pursuant to this Section 11 shall be rounded down to the nearest whole number of Shares. Under no circumstances shall the Company be required to authorize or issue fractional shares. To the extent permitted by applicable law, no consideration shall be provided as a result of any fractional shares not being issued or authorized.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 12.  EFFECT OF A CHANGE IN CONTROL</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger or Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that the Company is a party to a merger or other reorganization, outstanding Awards shall be subject to the agreement of merger or reorganization. Such agreement may provide, without limitation, that subject to the consummation of the merger or other reorganization, for the assumption (or substitution) of outstanding Awards by the surviving corporation or its parent, for their continuation by the Company (if the Company is a surviving corporation), for accelerated vesting and&#47;or for their cancellation with or without consideration, in all cases without the consent of the Participant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise provided in the applicable Award Agreement (and in such case the applicable Award Agreement shall govern), in the event that a Change in Control occurs and there is no assumption, substitution or continuation of Awards pursuant to Section 12(a), the Committee may in its discretion </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide that all Awards shall vest and become exercisable as of immediately before such Change in Control. For avoidance of doubt, &#8220;substitution&#8221; includes, without limitation, an Award being replaced by a cash award that provides an equivalent intrinsic value (wherein for Equity Awards intrinsic value equals the difference between the market value of a Share and any per Share exercise price).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 13.  LIMITATIONS ON RIGHTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retention Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Plan nor any Award granted under the Plan shall be deemed to give any individual a right to remain in Service as an Employee, Consultant, Director or Non-Employee Director or to receive any other Awards under the Plan. The Company and its Parents and Subsidiaries and Affiliates reserve the right to terminate the Service of any person at any time, and for any reason, subject to applicable laws, the Company&#8217;s Articles of Incorporation and Bylaws and a written employment agreement (if any).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Regulatory Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any other provision of the Plan notwithstanding, the obligation of the Company to issue Shares or other securities under the Plan shall be subject to all applicable laws, rules and regulations and such approval by any regulatory body as may be required. The Company reserves the right to restrict, in whole or in part, the delivery of Shares or other securities pursuant to any Equity Award prior to the satisfaction of all legal requirements relating to the issuance of such Shares or other securities, to their registration, qualification or listing or to an exemption from registration, qualification or listing.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dissolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent not previously exercised or settled, Options, SARs, unvested Stock Units and unvested Restricted Stock Grants shall terminate immediately prior to the dissolution or liquidation of the Company and shall be forfeited to the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company may (i) cause the cancellation of any Award, (ii) require reimbursement of any Award by a Participant and (iii) effect any other right of recoupment of equity or other compensation provided under this Plan or otherwise in accordance with Company policies and&#47;or applicable law (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In addition, a Participant may be required to repay to the Company certain previously paid compensation, whether provided under this Plan or an Award Agreement or otherwise, in accordance with the Clawback Policy.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 14.  TAXES.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall make arrangements satisfactory to the Company for the satisfaction of any withholding tax obligations that arise in connection with his or her Award. The Company shall not be required to issue any Shares or make any cash payment under the Plan until such obligations are satisfied.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Committee in its discretion may permit or require a Participant to satisfy all or part of his or her withholding or income tax obligations by having the Company withhold all or a portion of any Shares that otherwise would be issued to him or her or by surrendering all or a portion of any Shares that he or she previously acquired (or by stock attestation). Such Shares shall be valued based on the value of the actual trade or, if there is none, the Fair Market Value as of the previous day.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any payment of taxes by assigning Shares to the Company may be subject to restrictions, including, but not limited to, any restrictions required by rules of the SEC. The Committee may also, in its discretion, permit or require a Participant to satisfy withholding or income tax obligations (up to the maximum amount permitted by applicable law) related to an Equity Award through a sale of Shares underlying the Equity Award or, in the case of Options, through Net Exercise or Cashless Exercise.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 15.  DURATION AND AMENDMENTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Term of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan was originally effective on the Adoption Date and was amended on November 16, 2017, January 19, 2018, September 20, 2018 and August 27, 2020. In any event, the Plan shall terminate no later than on the day before the tenth anniversary of the Adoption Date.  The Plan may be terminated by the Board on any earlier date pursuant to Section 15(b).  This Plan will not in any way affect outstanding awards that were issued under the Prior Equity Compensation Plans or other Company equity compensation plans.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Amend or Terminate the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board may amend or terminate the Plan at any time and for any reason. No Awards shall be granted under the Plan after the Plan&#8217;s termination. An amendment of the Plan shall be subject to the approval of the Company&#8217;s stockholders only to the extent required by applicable laws, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations or rules. In addition, no such amendment or termination shall be made which would impair the rights of any Participant, without such Participant&#8217;s written consent, under any then-outstanding Award, provided that no such Participant consent shall be required with respect to any amendment or alteration if the Committee determines in its sole discretion that such amendment or alteration either (i) is required or advisable in order for the Company, the Plan or the Award to satisfy or conform to any law or regulation or to meet the requirements of any accounting standard, or (ii) is not reasonably likely to significantly diminish the benefits provided under such Award, or that any such diminishment has been adequately compensated. In the event of any conflict in terms between the Plan and any Award Agreement, the terms of the Plan shall prevail and govern.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 16.  EXECUTION</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To record the adoption of this Plan by the Board, the Company has caused its duly authorized Officer to execute this Plan on behalf of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LIFEVANTAGE CORPORATION</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Steven R. Fife</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58; Steven R. Fife</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58; Interim President and CEO, CFO</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lfvn-20201112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfvn="http://www.lifevantage.com/20201112" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lifevantage.com/20201112">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20201112_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20201112_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20201112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20201112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lifevantage.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>lfvn-20201112_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20201112.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>lfvn-20201112_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20201112.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended" id="i6f1da87f04af45df959984c064f5f9e1_CoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lfvn-20201112_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_d2d7e808-2707-49d4-95b9-adf98bd1c3f3_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_fb7c2658-77b9-4803-82be-c6149e8570b7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c3708490-f10d-4f0d-803e-d98c279a4e5f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c8720787-40d9-493b-9bdd-272075955dc3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_7ee6b32e-a8e0-4939-9fb2-9bb4e2ac89cc_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_223cbdbc-7c9c-4cd3-a7b1-8f8c9a255f49_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1623875f-e21e-4e67-942e-c068ee862a77_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_26dc8626-8fd5-474b-9c02-fab0ea4568bf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_afef1151-3e4e-4fc8-b213-360a1cdf8129_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b6f0ac6b-206b-4718-a63c-d98d96dfd520_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c7c16910-1a6c-4ec5-8df7-0c8ff47c9760_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_368e7758-a4a2-4f46-932a-da758c4185e9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a3c02324-a5fc-4e1e-9e38-6e6e01f61836_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6d54ed80-3d93-4daa-80e8-9b9a48603660_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7b0eaec0-4b97-486a-990c-86eff810dc26_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_02e2b465-e91f-49c4-a415-a4c0e42d052f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_6d357ce6-27c9-4556-8cfb-8189c9748aba_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f82942ec-3508-4481-952f-86af80972f16_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_db5e58f9-6288-4230-9be8-bdf33e6e60f4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_de2102b1-f94c-41d4-a14d-c8a32d7a11c1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9f809243-52ca-4c08-986a-f329dc876bff_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_de9d30d8-ae1e-4ba2-89c9-1de8a2e71866_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8b4e50f6-8c82-44b1-828a-daba48239695_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8cd2429e-903e-432c-b29e-23d3245c0ab5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lfvn-20201112_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d9b282ec-c77a-4b04-9da5-e0dd0d255374,g:5def6411-2e83-49dc-927b-599cd2896556-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20201112.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_63ab1e7b-3841-41b5-83ac-599423541844" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_DocumentType_63ab1e7b-3841-41b5-83ac-599423541844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_da1172d1-2c8d-4922-8776-9f7d18027b51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_DocumentPeriodEndDate_da1172d1-2c8d-4922-8776-9f7d18027b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_251488ad-bfa7-4829-b0a4-eb41e2cbf7da" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityRegistrantName_251488ad-bfa7-4829-b0a4-eb41e2cbf7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9310cb9a-538e-47d6-b23a-15bbd6dcdad7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityCentralIndexKey_9310cb9a-538e-47d6-b23a-15bbd6dcdad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_908e7d38-e28e-45e0-920f-3bcdfe61a3d6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_AmendmentFlag_908e7d38-e28e-45e0-920f-3bcdfe61a3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8a6c3743-d421-426f-8c27-04b71c037a8e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8a6c3743-d421-426f-8c27-04b71c037a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_50e0f665-ea2d-4e09-af7f-b8ee303cbafa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityFileNumber_50e0f665-ea2d-4e09-af7f-b8ee303cbafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c5585b81-f6f9-47a8-80d6-f360ee9786fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityTaxIdentificationNumber_c5585b81-f6f9-47a8-80d6-f360ee9786fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_400b5211-59e8-485e-832c-9d1e717c03a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityAddressAddressLine1_400b5211-59e8-485e-832c-9d1e717c03a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_d5b395f2-e505-455f-b803-de9d3154285d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityAddressAddressLine2_d5b395f2-e505-455f-b803-de9d3154285d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6f94200c-fcd6-46c5-9572-def248a71068" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityAddressCityOrTown_6f94200c-fcd6-46c5-9572-def248a71068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_516fe0f9-3f3d-4600-8130-2d04f8dc0600" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityAddressStateOrProvince_516fe0f9-3f3d-4600-8130-2d04f8dc0600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f2ba9c96-5195-4f4c-b0a6-da8929c9d087" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityAddressPostalZipCode_f2ba9c96-5195-4f4c-b0a6-da8929c9d087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2b73662f-1944-4405-8614-4adaae93561a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_CityAreaCode_2b73662f-1944-4405-8614-4adaae93561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bd17cd48-589b-45dd-86f2-0b9213ddc089" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_LocalPhoneNumber_bd17cd48-589b-45dd-86f2-0b9213ddc089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8fe37936-2495-4bf0-bdc9-9c90935d7c03" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_WrittenCommunications_8fe37936-2495-4bf0-bdc9-9c90935d7c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2558f4e8-6abd-486b-91c0-e1ab45802e0f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_SolicitingMaterial_2558f4e8-6abd-486b-91c0-e1ab45802e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f37e0221-523a-42e4-be68-4eb8e55dfd5d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_PreCommencementTenderOffer_f37e0221-523a-42e4-be68-4eb8e55dfd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_8ffd5300-638c-49f8-80c8-373b478168f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_8ffd5300-638c-49f8-80c8-373b478168f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1b2b0370-aea6-47f1-9a31-c5bab6e5154e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_Security12bTitle_1b2b0370-aea6-47f1-9a31-c5bab6e5154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dd8676fe-1319-4d68-ab01-cfeb7ee8e573" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_TradingSymbol_dd8676fe-1319-4d68-ab01-cfeb7ee8e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_75c7911b-2da7-46a1-88f8-a3ed53b8b7c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_SecurityExchangeName_75c7911b-2da7-46a1-88f8-a3ed53b8b7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ac89da5c-2185-4c4c-992c-7dbc1f9d089a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2b7472eb-e2d3-4c4a-b689-82dd6f93a143" xlink:to="loc_dei_EntityEmergingGrowthCompany_ac89da5c-2185-4c4c-992c-7dbc1f9d089a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>lfvn-20201112_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lfvn-20201112.xsd" xlink:type="simple"/>
    <context id="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2020-11-12</startDate>
            <endDate>2020-11-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl80L2ZyYWc6YzQyZTQ2ODY1YjJlNDM5ZWI3NWQyYzk3OTg5YTQ2OWIvdGFibGU6OTU2MzJiMTU3YjkzNDk2MTg1N2JiZDg2YTZjNjUzZmUvdGFibGVyYW5nZTo5NTYzMmIxNTdiOTM0OTYxODU3YmJkODZhNmM2NTNmZV8yLTEtMS0xLTA_facbbb30-3546-46d0-83bf-ef24114ccb74">0000849146</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl80L2ZyYWc6YzQyZTQ2ODY1YjJlNDM5ZWI3NWQyYzk3OTg5YTQ2OWIvdGFibGU6OTU2MzJiMTU3YjkzNDk2MTg1N2JiZDg2YTZjNjUzZmUvdGFibGVyYW5nZTo5NTYzMmIxNTdiOTM0OTYxODU3YmJkODZhNmM2NTNmZV81LTEtMS0xLTA_e805cb22-2e62-4193-9cf6-6c90a2a8168d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg1_fdf22042-29fc-4c0f-980e-9897171cbaf1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8xMDk5NTExOTMxNjk1_e97c8693-7e95-4f56-a342-42a94f940c66">2020-11-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg2_d840355f-b461-4b6f-9b84-c5312274f8db">LIFEVANTAGE CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTAtMS0xLTA_c80c169b-c799-44b3-9d38-938ef4f4aa74">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTItMS0xLTA_e74e9174-c3d5-488d-881f-5c06006ce05e">001-35647</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzUzZmMwZDc1ZTMxNDQwNGFlNDIzY2MxOTBmMDY2YmMvdGFibGVyYW5nZTpjNTNmYzBkNzVlMzE0NDA0YWU0MjNjYzE5MGYwNjZiY18wLTUtMS0xLTA_81fb862d-b68b-4729-b96b-bb7771fd7988">90-0224471</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg3_da89e1a0-6ea8-453d-ac0d-2e679921b3e3">9785 S. Monroe Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkx_de7e0fd7-7b38-4631-9e66-d6f0fc0ae322">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzky_1180789f-b75a-4844-9210-a99e7ce9005b">Sandy</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg0_bca28d30-86a3-4cd8-b51e-594de38c7a29">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkz_ebd75ea0-f897-443d-9049-9abb16a361ca">84070</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg4_cb7b2c17-9cc9-4eae-a704-cb02a7ac3404">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzg5_0cb71eb2-c694-4743-b3c9-64f6ba1af50c">432-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18wLTAtMS0xLTA_0a7e8bd4-cb76-4607-bbbd-1fdda6432bd9">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18xLTAtMS0xLTA_f192088e-8573-457c-b223-2ab50a2d49d8">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18yLTAtMS0xLTA_4a5da456-28ef-4abd-9e49-f1ce72c6f22f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6YzNkZTM5M2RhODg1NDRjM2JhZjdiMWE0ZDZiMTQyMGMvdGFibGVyYW5nZTpjM2RlMzkzZGE4ODU0NGMzYmFmN2IxYTRkNmIxNDIwY18zLTAtMS0xLTA_9c856e30-a26b-4264-9cc3-5cdeea801b63">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTAtMS0xLTA_81d991a6-2234-45e1-8b0a-01dc2c013ab2">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTItMS0xLTA_c7b25340-5aee-4252-a78f-311b758682bf">LFVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGFibGU6ZTkxYmVmMTcxYjc3NDVmZTkxNjg3MjdkMDE3ODUxZGMvdGFibGVyYW5nZTplOTFiZWYxNzFiNzc0NWZlOTE2ODcyN2QwMTc4NTFkY18wLTQtMS0xLTA_76273a2e-8957-43c8-ad98-e603fef8890f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOmMxMzhmZDQxZmYxYTQyMThiZjA0NGI3NDk4NWFiZmU2L3NlYzpjMTM4ZmQ0MWZmMWE0MjE4YmYwNDRiNzQ5ODVhYmZlNl8xL2ZyYWc6ZTUxN2U5MTVlYmEwNGRlNjg2NDFmNjY4MjFiN2E1ZDQvdGV4dHJlZ2lvbjplNTE3ZTkxNWViYTA0ZGU2ODY0MWY2NjgyMWI3YTVkNF8yMzkw_fa736eb2-fc28-4375-b59f-a36e3dd652f4">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139674660878360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 12, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 12,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEVANTAGE CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000849146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0224471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9785 S. Monroe Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sandy<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFVN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *V <5$'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "M@'%1C5<C*^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R$YI!R;U96.G#08K;.QF9+4UBQ-C:R1]^R59FS*V!]C1TN]/
MGT U1HU=HN?414KL*=\,H6FSQK@51^:H 3(>*=A<CHEV;.Z[%"R/SW2 :/'#
M'@@J*3<0B*VS;&$"%G$A"E,[U)C(<I?.>(<+/GZF9H8Y!&HH4,L95*E F&EB
M/ U-#5? !&-*(7\7R"W$N?HG=NZ .">'[)=4W_=EOYISXPX*WIX>7^9U"]]F
MMBW2^"M[S:=(6W&9_+JZN]\]"%/)2A9*%>IVIS9:KG6U?I]<?_A=A4/G_-[_
M8^.+H*GAUUV8+U!+ P04    " "M@'%1F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *V <5%M 2C=1 0  ,@0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MG9A1;^HV%,>?[SZ%A?:P26V3F+3 %46BE-ZAVU+6<'NE37LPB0&KB9TY3BG?
M?L<!$G873M#Z4.*0\\_/Y]A_V_0W2K]E:\X-^4ABF=VVUL:DGQTG"]<\8=F5
M2KF$;Y9*)\Q 4Z^<+-6<1450$CO4=6^<A G9&O2+>S,]Z*O<Q$+RF299GB1,
M;^]XK#:W+:]UN/$B5FMC;SB#?LI6/.#F6SK3T')*E4@D7&9"2:+Y\K8U]#[?
MT6L;4#SQ*O@F.[HFMBL+I=YL8Q+=MEQ+Q&,>&BO!X..=CW@<6R7@^'LOVBK?
M:0./KP_J#T7GH3,+EO&1BK^+R*QO6]T6B?B2Y;%Y49O?^+Y#!6"HXJSX3S:[
M9WV_1<(\,RK9!P-!(N3NDWWL$W$4T*8G N@^@!;<NQ<5E/?,L$%?JPW1]FE0
MLQ=%5XMH@!/25B4P&KX5$&<&(_7.-9E! ?J. 3U[UPGWL7>[6'HB=JK>KXA'
M+PAUJ?OO< <P2A9:LM!"KXVR_#E<9$9#M?Y")-NE9+N0]$](WJLPAS%DR'R;
MUO80#^]>?D4@_!+"/P]BQK50$1G+B$"Q:GEPI4/&?_KTJ2'GUR7;-:HXED:8
M+7GA*V&S#I!3EM22X3J/DX?QZW Z'WX9D]'SRPQ!NRG1;LY!&T'F-(O)1$;\
M@WSEVSHX7,F%OZ[?\_P;!*M38G50L2&4,BK*^1"S51T,'K]D<<81CF[)T3TG
M/1,9*ITJS:S)79# P, B2I.1RB%OD#X5U983%[\?(X2]DK!W#N&#B#F9YLF"
MZSH07,-UO<OV]8W?07@\MS([]QRB.?L@DPA**)8B+!*'\#5(]MQ+EU+?[W@8
MX9$=>^<0#J-(\RR[.%R01WB./,MZE\8E>YWN-0FNR).26G$8(1H6"PRV\FN/
M_G_8^4;5PN*202Y@_/HNYFU>Y?X>[M\_ HYL"R;'7&UD+1PN%S 9;3&P:D7P
M<"/_$:R<MC.MWH4,Z^N,:WZ;8VC5@N"=M2*4:#.5&;#?/T1ZTDL:%+N^VT'K
M6:T('F[D1?V&L/L\C8(+=%UTFE9K@(>;^*,*(2>SM9*8M36(^&UZV7/QH5ZM
M!A[NV-^U,(9+2$R2Y')O:UDM%2[4M#YYE?U[N'<'*A:A,$*NR!,,;RU87,N#
MJS3QT,K]*6[5,\TO0T@/A_FUVQ3"2@X[SN?ELKY^#7J-9)7K4]RB_T,VR;(<
MR!H!<=E&P*.=.6[+<V%@$5=+V'S^LOB5!#S,8;S5;L4:E.SXA/4V,"I\NR I
MT^2=Q3DG/[M7,!6PV4DKVZ>X3\\UB^RH"[;)0M6.N0:!QX?7*492^3S%/?F0
M*#+^"-=,KOC)[76#T'08W ]_QY@J@Z=G&?PXX7IEL_0%%,S:&D?*9'U)<<&3
MP\PY.I?:,_X3LV_,2,R7(.1>=4!7[X[-NX91:7%472@#!]_B<LT93 '[ 'R_
M5,H<&O;T6_YX,?@'4$L#!!0    ( *V <5&#J:4#U $  #(&   -    >&PO
M<W1Y;&5S+GAM;-55VXK40!#]E:8_P)Y$=D%) BHL""H+.P^^=I)*TM W.Y4Q
MV:^W.YW;N RH#Z(ODSJGJD^=OD[6XR3AJ0- ,BJI^YQVB/8M8WW5@>+]*V-!
M^TQCG.+HH6M9;QWPN@^#E&3IZ73/%!>:%ID>U(/"GE1FT)C3$V5%UAB],Z]I
M)'PI5T N7.;T Y>B=&*NY4K(*=)I("HCC2/HK4!.D\#TSS&=1!1<+CI*:.,"
MR6*'^%LNY3\E5M1[**3<#*8T$D5F.2(X_>#!7#R3+U)DB<^3]0Y;QZ<DO:/[
M@/GCFY3&U>"V-@E=J2*3T 0[3K1=^**Q+"01C?)!+7AK-)\]K".6P,M6(.53
MV,*OS97VV)"X%Q_KL TD3'4-O:$EC#(1!/VC6M0^R-[]D2RQXF+P_>!GHV?\
M;3 (CPX:,<YX;+;^M]23V^K<6CF]DZ+5"N+<?[EAD?%U'.F,$\^^6S@IE2?
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MB^$_7G\!4$L! A0#%     @ K8!Q40=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "M@'%1C5<C*^X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *V <5&7BKL<P    !,"   +
M      "  88.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *V <5$9117U-P$
M "<"   /              "  6\/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " "M@'%1)!Z;HJT   #X 0  &@              @ '3$   >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "M@'%199!YDAD!  #/
M P  $P              @ &X$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"   "$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lfvn-20201112.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lfvn-20201112.htm">lfvn-20201112.htm</File>
    <File>a2017ltip.htm</File>
    <File>lfvn-20201112.xsd</File>
    <File>lfvn-20201112_cal.xml</File>
    <File>lfvn-20201112_def.xml</File>
    <File>lfvn-20201112_lab.xml</File>
    <File>lfvn-20201112_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lfvn-20201112.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "lfvn-20201112_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfvn-20201112_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lfvn-20201112.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lfvn-20201112_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfvn-20201112_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lfvn-20201112.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lfvn",
   "nsuri": "http://www.lifevantage.com/20201112",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20201112.htm",
      "contextRef": "id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.lifevantage.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20201112.htm",
      "contextRef": "id1e8ca2ddd51478686b8e39490f33dec_D20201112-20201112",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000849146-20-000179-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000849146-20-000179-xbrl.zip
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M#W?X(8=3W$GZ?&>RN_-\US[Z]-.8)?)X7.^*&4=2"[88QE9E9;,4)F7B3HK
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MTE$VVR' C_[=%#;IJBM@<J[S*(L\'4<8@H1IXANQN.SN1Y>TR?M+0_MK0NG
MAPNDK& 8XK)SNZ6&=5IAIN1?)MF@C&X?'G/* UW"0 <B,9^V4V+ZF<HW07A
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M>7&1SKL3L66XW!$M@7+"1-+SY*/1#*Q?H+F6/^6)X82%=1T'N4R?DG?/2E[
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M,\EP\,/TD*PVHVC*YY:XW:'?.M /W$8L#,C?YR(N6J_;&$Y['=LE>D%ZN6<
MNXR0GA>2WS)$[$US:8,BY-I4T=ID,I=Z9%EQ"Q?\1^#/L<J_)BDR>Q-B#&"S
MS[>P<*BT*A[(9*R>C0RTS;5+Y5'VU25F&8OF,L'#F8UUV$4XB%.DBB#W2(PE
M76PB#G_RB7.:R9@Z73!G+^RT="&8+[;H2&-A>K1U%Z;A9Q R1G/-1/ '@YGD
MU9C9TA3E=9*GOUK")@DS->.Z*87\^+I,YK(Q">K-E0AX7HWA>&5#C)L7"/QP
M&+.V>M)@@&4"9GN:HTN,2,X2NR/2?($FFU<=8TB%N_J%5&$W^0YP=""T(B8
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M.6P?6^FGXIJ:X 4_+N!T)@M;V)5^ AU33,A$$I^H;;J0@T0>&CY4[A?M=+,
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MCCA^1\-CD**N&2]&N.:C*6H_4TU_W%33=DE]3H#@PE--+SNS]/;-+3Z'H\R
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M+'_GM(T=.$/:G@F2GQU)_/GR8[V\@[=6.K)]S8F] ?P/;,YPX_\!4$L#!!0
M   ( *V <5&?#'#[D (  (T)   1    ;&9V;BTR,#(P,3$Q,BYX<V3=5EUO
MFS 4?<^O\'B>PT="$U"32FM5:5+VH:Y5^S89^T*L@LULDZ3_OH; 4M*T:Z8]
M;).0,-?WG.MS?7W-Z=FFR-$*E.92S!Q_Z#D(!)6,BVSFW%Q?XJES-A\,3M]A
M?/?A:H$N)*T*$ :=*R &&%ISLT2W#/0]2I4LT*U4]WQ%,)XWH'-9/BB>+0T*
MO,#;GU4QBY)@&@#%=#(A>)QX8QPQ$F+P&/-8$(:CR?A]%H<,TI.Q[^, IB,\
MCAC%43!)<!A%E 73Z"0,3QK2C8XU74)!D!4F=+S1,V=I3!F[[GJ]'JY'0ZDR
M-_ \W[W[M/C6N#JM;\[%?<][DZB\\Q^Y]71"-/QT3U>BYY[S%%9$&)+!D,K"
MK17[OA\XB!BC>%(9N)2JN("45+F9.97X41$+XL!LUG.H\]IS>#)MB,K ?"8%
MZ))0>%O<^0"A.B.\**4R2!Q$MRGQHRAR-[5&!VTSN)"4F*8L7DQ)XX_K(?8#
M//*'&\T<]TUA^T1<:$,$A6-BVR_<X?[$&G;[>]P:.MSQ:VC(--!A)E<N VY)
M_0A[OF4XO C]$J@>X!VZ'Y\((4W#4EM:6UERD<JMP9IJ$7&GY K2[O@\.Q,'
MRJ5YQ411)?-?U)9;*EF",ASTT_/4$"P5I#.G/E6XJ^#OE.1#NY+.Y5F _G;4
MTZZ%T"IOY"YV>CH&\U!:!FVW)(=MAOYF^;;K'2O?0KC@_X7ZG"3'JK<0R/]Y
MX:6"8X5;B+;7Q^^4?8V_MO.(LYES+NW/P%=[DSBHMM]<?7SUJFEB[S =<4>]
M*\:Y9Z]<^R"\^X7 J$&B&GKJ[@/VJ"H-[(N8-^-]L2VX=7D%N-<;WHSK'ZJ#
ML-;8);/MM&Z_U6Z_G[3CQK#M]//!(U!+ P04    " "M@'%1P<]+!(@!  #8
M @  %0   &QF=FXM,C R,#$Q,3)?8V%L+GAM;)V276_;(!2&[_,KF'<[;$/L
M)%AQ*BW3I$F95&6KVEL,QS:*#1'0V/WW,UX_U+73I-V SCD/YST?;*_&OD,7
ML$X9748D3B,$6ABI=%-&-S^_XDUTM5LLMA\POOM\/* O1MSWH#W:6^ >)!J4
M;]&M!'="M34]NC7VI"X<X]W\:&_.#U8UK4<TI>F?45M(5M$-!8'%>LUQ5J49
M9I+G&%(I4TGS?+G./C5%+J%>981@"ILESI@4F-%UA7/&A*0;MLKSU9RT4_I4
MA*/B#M#4G':S64:M]^<B289AB,?*=K&Q34+3=)D\T=$C/K[AA^5,$\98,D>?
M4:?> Z>T)+G[?O@A6N@Y5MIYKD40<*IPL_-@!/?SS/]9%_HK$2S\A.'@PH3B
M)8E')Z/= J'?X["F@R/4*-PWQV^O)#M5PX5KSQN(A>F3P"1[,_V(Z\DU53QG
M\ ]G*".G^G/W[&LMU&74U1>-PVH)(33H?GQYG+R4('@G[KNYX\-D/Z8(8O]=
M#8P>M 099+;)J[WO%K\ 4$L#!!0    ( *V <5%'$KO&#@(  ($&   5
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MU=Z$#5-=7;GJ4&/W,M&[TIJM#UQO]X:X6W7W#^^^< .BY#*K9G+J(XD2'(5
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MJ%O&M4EXD_<+=?3FV?I,MOPG"&^>_1]02P,$%     @ K8!Q482TW ;@!@
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M\%D  &QF=FXM,C R,#$Q,3(N:'1M4$L! A0#%     @ K8!Q49\,</N0 @
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M,#(P,3$Q,E]L86(N>&UL4$L! A0#%     @ K8!Q482TW ;@!@  F#,  !4
M             ( !W(4  &QF=FXM,C R,#$Q,3)?<')E+GAM;%!+!08
..!P ' ,4!  #OC      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
